Spots Global Cancer Trial Database for CYP2D6 Genotype on the Clinical Effect of Tamoxifen
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: CYP2D6 Genotype on the Clinical Effect of Tamoxifen
Official Title: Impact of CYP2D6 Genotype on the Clinical Effects of Tamoxifen Using With Samples From Prospective Randomized Multicenter Study
Study ID: NCT00973037
Interventions
Study Description
Brief Summary: The purpose of this study is to investigate the impact of CYP2D6 Genotype on the clinical effects of tamoxifen using with samples from prospective randomized multicenter study(ASTRRA).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Korea University Anam Hopital, Seoul, , Korea, Republic of
Contact Details
Name: Eun Sook Lee, MD, PhD
Affiliation: Korea University Anam Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
